Amphotericin B and Caspofungin Resistance in Candida glabrata Isolates Recovered from a Critically Ill Patient

Amphotericin B: spectrum and resistance

Ellis, D. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.7 · Cited by 474

Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000

Pfaller, M. A., Diekema, D. J., Jones, R. N., Messer, S. A., & Hollis, R. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.852-856.2002 · Cited by 331

Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors

OXFORD, J. S., Bossuyt, S., Balasingam, S., Mann, A., Novelli, P., & Lambkin‐Williams, R. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00564.x · Cited by 231

Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts

Rodríguez-Tudela, J. L., Barchiesi, F., Billé, J., Chryssanthou, E., Cuenca‐Estrella, M., Denning, D. W., Donnelly, J. P., Dupont, B., Fegeler, W., Moore, C. B., et al. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00789.x · Cited by 208

Detection of amphotericin B-resistant Candida isolates in a broth-based system

Rex, J. H., Cooper, C. R., Merz, W. G., Galgiani, J. N., & Anaissie, E. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.906 · Cited by 198

Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002

Pfaller, M. A., Messer, S. A., Boyken, L. B., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.3142-3146.2004 · Cited by 183

Seminational Surveillance of Fungemia in Denmark: Notably High Rates of Fungemia and Numbers of Isolates with Reduced Azole Susceptibility

Arendrup, M. C., Fuursted, K., Gahrn-Hansen, B., Jensen, I. M., Knudsen, J. D., Lundgren, B., Schønheyder, H. C., & Tvede, M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4434-4440.2005 · Cited by 177

In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model

Arendrup, M. C., Horn, T. D., & Møller, J. K. (2002) · Infection · doi:10.1007/s15010-002-2131-0 · Cited by 169

Caspofungin Resistance in Candida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis

Hernandez, S., López-Ribot, J. L., Najvar, L. K., McCarthy, D. I., Bocanegra, R., & Graybill, J. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1382-1383.2004 · Cited by 162

Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome

Kartsonis, N. A., Killar, J., Mixson, L. A., Hoe, C., Sable, C. A., Bartizal, K. F., & Motyl, M. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3616-3623.2005 · Cited by 138

Emergence of Resistance to Amphotericin B and Triazoles inCandida glabrataVaginal Isolates in a Case of Recurrent Vaginitis

Khan, Z., Ahmad, S., Al‐Obaid, I., Al‐Sweih, N., Joseph, L., & Farhat, D. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.4.488 · Cited by 31

Antifungal Therapy for Invasive Fungal Diseases in Allogeneic Stem Cell Transplant Recipients: An Update

Wilson, D. T., Drew, R. H., & Perfect, J. R. (2009) · Mycopathologia · doi:10.1007/s11046-009-9193-9 · Cited by 31

The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine

Chamilos, G., & Kontoyiannis, D. P. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000235166.16421.e5 · Cited by 30

Candida glabrata : new tools and technologies—expanding the toolkit

Ho, H.-L., & Haynes, K. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov066 · Cited by 29

Molecular Species Identification of Candida from Blood Samples of Intensive Care Unit Patients by Polymerase Chain Reaction – Restricted Fragment Length Polymorphism

Vijayakumar, R., Giri, S., & Kindo, A. J. (2012) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.98661 · Cited by 29

Functional characterization and virulence study ofADE8 andGUA1genes involved in thede novopurine biosynthesis inCandida albicans

Jiang, L., Zhao, J., Guo, R., Li, J., Yu, L., & Xu, D. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00600.x · Cited by 29

Candidemia in intensive care unit patients

Giri, S., Kindo, A., & Kalyani, J. (2013) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.118036 · Cited by 29

Future therapies targeted towards eliminatingCandidabiofilms and associated infections

Bandara, N., Matsubara, V. H., & Samaranayake, L. P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1268530 · Cited by 29

Caspofungin‐resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report

Eschertzhuber, S., Velik‐Salchner, C., Hoermann, C., Hoefer, D., & Lass‐Flörl, C. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00252.x · Cited by 28

Antifungal Susceptibility Testing and Identification

Kidd, S. E., Crawford, L. C., & Halliday, C. L. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.004 · Cited by 31

Interlaboratory Reproducibility of Etest Amphotericin B and Caspofungin Yeast Susceptibility Testing and Comparison with the CLSI Method

Ranque, S., Lachaud, L., Gari-Toussaint, M., Michel-Nguyen, A., Mallié, M., Gaudart, J., & Bertout, S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00490-12 · Cited by 25

p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis

Ferreira, P. S., Victorelli, F. D., Rodero, C. F., Fortunato, G. C., Araújo, V. H. S., Fonseca‐Santos, B., Bauab, T. M., Dijck, P. V., & Chorilli, M. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120658 · Cited by 25

Management of Candida Biofilms: State Of Knowledge and New Options for Prevention and Eradication

Bujdáková, H. (2016) · Future Microbiology · doi:10.2217/fmb.15.139 · Cited by 27

The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia

Sobel, J. D. (2007) · Current Fungal Infection Reports · doi:10.1007/s12281-007-0007-6 · Cited by 24

Oral mucositis caused by Candida glabrata biofilms: failure of the concomitant use of fluconazole and ascorbic acid

Rodrigues, C. F., & Henriques, M. (2017) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936116684477 · Cited by 24

Selected Essential Oils as Antifungal Agents Against Antibiotic-Resistant Candida spp.: In Vitro Study on Clinical and Food-Borne Isolates

Rajkowska, K., Kunicka‐Styczyńska, A., & Maroszyńska, M. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0001 · Cited by 23

The Susceptibility Patterns of Candida Species Isolated From Urine Samples to Posaconazole and Caspofungin

Mahmoudabadi, A. Z., Rezaei‐Matehkolaei, A., & Ghanavati, F. (2015) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.24298 · Cited by 22

Treatment of invasive candidiasis with echinocandins

Glöckner, A., Steinbach, A., Vehreschild, J. J., & Cornely, O. A. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01645.x · Cited by 22

Candida glabrata's recurrent infections: biofilm formation during Amphotericin B treatment

Rodrigues, C. F., Silva, S., Azeredo, J., & Henriques, M. (2016) · Letters in Applied Microbiology · doi:10.1111/lam.12600 · Cited by 21

Comparison of Anidulafungin MICs Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Method (M27-A3 Document) and Etest for Candida Species Isolates

Espinel‐Ingroff, A., Cantón, R., Pemán, J., & Martín‐Mazuelos, E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01324-09 · Cited by 21

Antifungal therapy for newborn infants with invasive fungal infection

Clerihew, L., & McGuire, W. L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003953.pub3 · Cited by 21

Candida

Dignani, M. C., Solomkin, J. S., & Anaissie, E. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00008-6 · Cited by 19

Mutants in the Candida glabrata Glycerol Channels Are Sensitized to Cell Wall Stress

Beese‐Sims, S. E., Pan, S., Lee, J., Hwang-Wong, E., Cormack, B. P., & Levin, D. E. (2012) · Eukaryotic Cell · doi:10.1128/ec.00231-12 · Cited by 17

A Review on Molecular Mechanisms of Antifungal Resistance in Candida glabrata : Update and Recent Advances

Lotfali, E., Fattahi, A., Sayyahfar, S., Ghasemi, R., Rabiei, M. M., Fathi, M., Vakili, K. G., Deravi, N., Soheili, A., Toreyhi, H., et al. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0235 · Cited by 18

Candida glabrata: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen

Pfaller, M. A., Castanheira, M., Lockhart, S. R., & Jones, R. N. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0091-0 · Cited by 17

The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran

Kooshki, P., Rezaei‐Matehkolaei, A., & Mahmoudabadi, A. Z. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.02.010 · Cited by 18

Whole-Genome Sequence Analysis of Candida glabrata Isolates from a Patient with Persistent Fungemia and Determination of the Molecular Mechanisms of Multidrug Resistance

Lim, H. J., Choi, M. J., Byun, S. A., Won, E. J., Park, J.-H., Choi, Y. J., Choi, H., Choi, H.-W., Kee, S., Kim, S. H., et al. (2023) · Journal of Fungi · doi:10.3390/jof9050515 · Cited by 18

Echinocandin Antifungal Drug Resistance in Candida Species: A Cause for Concern?

Sanguinetti, M., Posteraro, P., & Posteraro, B. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0131-2 · Cited by 16

Isolation of cholesterol-dependent, multidrug-resistant Candida glabratastrains from blood cultures of a candidemia patient in Kuwait

Khan, Z., Ahmad, S., Joseph, L., & Alobaid, K. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-188 · Cited by 16

Suspected encephalitis with Candida tropicalis and Fusarium detected by unbiased RNA sequencing

Christopeit, M., Grundhoff, A. T., Rohde, H., Campos, C. B., Grzyska, U., Fiehler, J., Wolschke, C., Ayuk, F. A., Kröger, N. M., & Fischer, N. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2770-3 · Cited by 16

Genome-Wide Response to Drugs and Stress in the Pathogenic Yeast Candida glabrata

Pais, P., Galocha, M., & Teixeira, M. C. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_7 · Cited by 17

Antifungal Resistance Testing and Implications for Management

Badali, H., & Wiederhold, N. P. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00354-6 · Cited by 16

Caspofungin Disk Diffusion Breakpoints and Quality Control

Brown, S. D., & Traczewski, M. M. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00279-08 · Cited by 15

Treatment of vaginitis caused by non-albicans Candida species

Sobel, J. D. (2024) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2347953 · Cited by 14

In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen

Amirrajab, N., Badali, H., Didehdar, M., Afsarian, M. H., Mohammadi, R., Lotfi, N., & Shokohi, T. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.36638 · Cited by 14

Antifungal Susceptibility of Candida Isolates at One Institution

Katsuragi, S., Sata, M., Kobayashi, Y., Miyoshi, T., Yamashita, Y., Neki, R., Horiuchi, C., Yamanaka, K., Kamiya, C., Iwanaga, N., et al. (2014) · Medical Mycology Journal · doi:10.3314/mmj.55.e1 · Cited by 13

In vitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest

Lovero, G., Giglio, O. D., Rutigliano, S., Diella, G., Caggiano, G., & Montagna, M. T. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000402 · Cited by 13

Candidemia in patients with prolonged fever in Kashan, Iran

Rezai, R., Momen–Heravi, M., Erami, M., & Nazeri, M. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.3.20 · Cited by 13

Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans

Akins, R. A., & Sobel, J. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_29 · Cited by 12

Emerging Prospects for Combating Fungal Infections by Targeting Phosphatidylinositol Transfer Proteins

Khan, D., Nile, A. H., Tripathi, A., & Bankaitis, V. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136754 · Cited by 11

Micafungin for the prophylaxis and treatment ofCandidainfections

Fritz, J. M., Brielmaier, B. D., & Dubberke, E. R. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.2.153 · Cited by 12

Evaluating Retinal Toxicity of Intravitreal Caspofungin in the Mouse Eye

Mojumder, D. K., Concepcion, F. A., Patel, S., Barkmeier, A. J., Carvounis, P. E., Wilson, J. H., Holz, E. R., & Wensel, T. G. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5541 · Cited by 11

Caspofungin: when and how? The microbiologist’s view

Mayr, A., Aigner, M., & Lass‐Flörl, C. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02039.x · Cited by 11

Antifungal susceptibility profile of invasive Candida glabrata isolates (2009–2020) from a tertiary care hospital laboratory in Pakistan

Memon, S., Farooqi, J. Q., Zafar, U., Naqvi, S. F., Zafar, A., & Jabeen, K. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001459 · Cited by 11

Candida glabrata vertebral osteomyelitis in an immunosuppressed patient

Tan, A. C., Parker, N., & Arnold, M. H. (2013) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12113 · Cited by 10

In-vitro pharmacokinetic/pharmacodynamic model data suggest a potential role of new formulations of posaconazole against Candida krusei but not Candida glabrata infections

Beredaki, M.-I., Arendrup, M. C., Mouton, J. W., & Meletiadis, J. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106291 · Cited by 10

Actividad antifúngica in vitro de la micafungina

Quindós, G., Eraso, E., Carrillo‐Muñoz, A. J., Cantón, E., & Pemán, J. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70006-3 · Cited by 9

Caspofungin MIC Distribution amongst Commonly Isolated Candida Species in a Tertiary Care Centre - An Indian Experience

Wanjare, S. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/23731.8883 · Cited by 10

Utility of Antifungal Susceptibility Testing and Clinical Correlations

Diekema, D. J., & Pfaller, M. A. (2011) · Humana Press eBooks · doi:10.1007/978-1-59745-134-5_8 · Cited by 9

Synthesis and Antifungal Screening of 2-{[1-(5-Alkyl/arylalkylpyrazin-2-yl)ethylidene]hydrazono}-1,3-thiazolidin-4-ones

Opletalová, V., Doležel, J., Kuneš, J., Buchta, V., Vejsová, M., & Kučerová-Chlupáčová, M. (2016) · Molecules · doi:10.3390/molecules21111592 · Cited by 9

For Debate: May the Use of the Polyene Macrolide Natamycin as a Food Additive Foster Emergence of Polyene-Resistance in Candida Species?

Dalhoff, A. (2017) · Clinical Microbiology Open Access · doi:10.4172/2327-5073.1000287 · Cited by 8

Epidemiology of Invasive Candidiasis and Challenges for the Mycology Laboratory: Specificities of Candida glabrata

Sampaio, P., & Pais, C. (2014) · Current Clinical Microbiology Reports · doi:10.1007/s40588-014-0002-y · Cited by 8

Strategies to manage antifungal drug resistance

Tseng, H.-K., & Perfect, J. R. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.517195 · Cited by 8

Actividad antifúngica in vitro de la anidulafungina

Quindós, G., & Eraso, E. (2008) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(08)70025-1 · Cited by 8

Investigation of the Defective Growth Pattern and Multidrug Resistance in a Clinical Isolate of Candida glabrata Using Whole-Genome Sequencing and Computational Biology Applications

Merdan, O., Şişman, A. S., Aksoy, S. A., Kızıl, S., Tüzemen, N. Ü., Yılmaz, E., & Ener, B. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00776-22 · Cited by 6

Hb40-61a: Novel analogues help expanding the knowledge on chemistry, properties and candidacidal action of this bovine α-hemoglobin-derived peptide

Carvalho, L. A. D. C., Remuzgo, C., Perez, K. R., & Machini, M. T. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.09.010 · Cited by 7

Anidulafungin and its role in candida infections

Cappelletty, D. M. (2009) · Infection and Drug Resistance · doi:10.2147/idr.s4796 · Cited by 7

Should Etest MICs for Yeasts Be Categorized by Reference (BPs/ECVs) or by Etest (ECVs) Cutoffs as Determinants of Emerging Resistance?

Espinel‐Ingroff, A., & Dannaoui, É. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00378-3 · Cited by 7

Review of the Current Management of Urinary Tract Infections due to Fluconazole-Resistant and Non-Albicans Candida Species

Tan, X., Baugh, K., Bulman, Z. P., & Wenzler, E. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00388-1 · Cited by 6

Antimicrobial activity of four medicinal plants widely used in Persian folk medicine

Hamedi, A., Zomorodian, K., & Safari, F. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 6

Evidencias científicas que respaldan el uso de micafungina en el tratamiento de la candidiasis invasora

Montejo, M., & Quindós, G. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(11)70004-0 · Cited by 6

CHANGING TRENDS OF CANDIDA ISOLATES AND THEIR ANTIFUNGAL SUSCEPTIBILITY PATTERN IN VULVOVAGINAL CANDIDIASIS CASES OF TRIPURA, NORTH EAST INDIA

Mullick, J. B., Majumdar, T., Ray, J., & Sil, S. K. (2015) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2015/2317 · Cited by 6

Nosocomial transmission of fluconazole-resistant Candida glabrata bloodstream isolates revealed by whole-genome sequencing

Hwang, I. J., Kwon, Y. J., Lim, H. J., Hong, K. H., Lee, H., Yong, D., Won, E. J., Byun, S. A., Lee, G. Y., Kim, S. H., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00883-24 · Cited by 5

In Vitro Susceptibilities of Non-albicans Candida Species to Echinocandins, Azoles, and Amphotericin B in Tokat, Turkey

Yenişehirli, G., Özveren, G., Yenişehirli, A., & Bulut, Y. (2018) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.59404 · Cited by 5

Antifungal Resistance: Cellular and Molecular Mechanisms

Araújo, R., & Espinel‐Ingroff, A. (2010) · Springer eBooks · doi:10.1007/978-3-642-12173-9_7 · Cited by 5

Candida bloodstream infection: A clinical microbiology laboratory perspective

Pongrácz, J., & Kristóf, K. (2014) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.61.2014.3.11 · Cited by 4

Candidiasis and Less Common Yeast Genera

Reiss, E., Shadomy, H. J., & Lyon, G. M. (2011) · Wiley eBooks · doi:10.1002/9781118101773.ch11 · Cited by 5

[1,3]Thiazolo[3,2-b][1,2,4]triazolium Salts as Effective Antimicrobial Agents: Synthesis, Biological Activity Evaluation, and Molecular Docking Studies

Slivka, M. V., Sharga, B. M., Pylypiv, D. B., Aleksyk, H., Korol, N. I., Fizer, M. M., Fedurcya, O. I., Pshenychnyi, O. G., & Mariychuk, R. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146845 · Cited by 7

Antifungal susceptibility profile and biofilm production of Candida spp. isolated from catheterised patients with urinary tract infection

Kamini, P., Thayanidhi, P., Karthika, K., & Bavadharani, S. (2022) · Journal of The Academy of Clinical Microbiologists · doi:10.4103/jacm.jacm_12_22 · Cited by 4

Susceptibility of Candida spp. clinical isolates to antimycotics and disinfectants

Staniszewska, M., Rozbicka, B., Rajnisz, A., Bocian, E., Wasińska, E., Jakimiak, B., Röhm-Rodowald, E., KURZĄTKOWSKI, W., & Tyski, S. S. (2010) · Open Life Sciences · doi:10.2478/s11535-010-0068-3 · Cited by 4

Caspofungin for the Treatment of Immunocompromised and Severely III Children and Neonates with Invasive Fungal Infections

Wiederhold, N. P., & Herrera, L. A. (2012) · Clinical Medicine Insights Pediatrics · doi:10.4137/cmped.s8016 · Cited by 6

Multidrug- and Cross-Resistant Candida: the Looming Threat

Lackner, M., Martín‐Vicente, A., & Lass‐Flörl, C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0210-1 · Cited by 4

Actividad in vitro de anidulafungina. Comparación con la actividad de otras equinocandinas

Martín‐Mazuelos, E., & Rodrı́guez-Tudela, J. L. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76587-x · Cited by 4

Reavaliação da suscetibilidade de Candida à anfotericina B: estudo comparativo com isolados de três hospitais do estado do Rio Grande do Sul

Boff, E., Lopes, P. G. M., Spader, T. B., Scheid, L. A., Loreto, É. S., Forno, N. L. F. D., Aquino, V. R., Severo, L. C., Santúrio, J. M., & Alves, S. H. (2008) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822008000100007 · Cited by 4

Echinocandins

Groll, A. H., Schrey, D., & Walsh, T. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_6 · Cited by 4

Is Timely and Appropriate Antifungal Drug Enough for Survival of Adult Cases with Candidaemia? Five-year Experience

Yıldırmak, T., Gedık, H., Şimşek, F., İris, N., & Gücüyener, A. (2014) · West Indian Medical Journal · doi:10.7727/wimj.2012.140 · Cited by 3

A Review of Antifungal Peptides: Basis to New Era of Antifungal Drugs

Akkam, Y. (2016) · Jordan Journal of Pharmaceutical Sciences · Cited by 3

Difficulties in antifungal therapy with amphotericin B and the continuous search for new formulations: A literature review

Ketllyn, S. V., rbara, L. F. B. A., lia, C. S. C. N. A., Raissa, H. D. M., Eliz, C. P. P., Jheneffer, D. I., Carraro, E., Guilherme, B. L. D. F., Weber, C. F. N. D. S., & Bonini, J. S. (2016) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp2015.4280 · Cited by 3

Successful treatment of Candida spp. encephalitis occurring under Caspofungin treatment after allogeneic stem cell transplantation

Behre, G., Christopeit, M., & Weber, T. E. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0551-3 · Cited by 3

Antifungal Alternatives for Invasive Candidiasis Refractory to Caspofungin in Liver Transplant Recipients: A Report of Two Cases

Choukroun, G., Thirion, M., Lortholary, O., Scatton, O., Conti, F., Calmus, Y., Paugam, A., & Pène, F. (2006) · Transplantation · doi:10.1097/01.tp.0000235988.51610.f7 · Cited by 3

Strategies for the management of Candida albicans infection

Vaishali, V., Khan, J., & Azmi, W. (2021) · Annals of Phytomedicine An International Journal · doi:10.21276/ap.2021.10.2.20 · Cited by 2

Echinocandine bei invasiven Candida-Infektionen

Glöckner, A., & Cornely, O. A. (2008) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-008-1058-3 · Cited by 2

Identification of Candida species from blood samples of neonates by PCR-RFLP method in Western U.P

Dutta, G., Verma, K., Kaur, K., & Bareja, R. (2024) · IP International Journal of Medical Microbiology and Tropical Diseases · doi:10.18231/j.ijmmtd.2024.041 · Cited by 1

Otilonium bromide exhibits novel antifungal activity against Candida albicans via regulating iron homeostasis

Hsu, L.-H., Chou, Y. Y., Shen, T., Wieczorek, D., & Chen, Y. (2025) · Virulence · doi:10.1080/21505594.2025.2609407 · Cited by 1

Pharmacotherapy of Micafungin: Clinical Review

Riddell, J., & Kauffman, C. A. (2009) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s3412 · Cited by 1

In-vitro Control of Oral Thrush Causal Organisms Using Medicinal Plants Extracts

Ebabhi, A. M., Adekunle, A. A., & OGHENERHABOKE, Y. I. (2019) · Notulae Scientia Biologicae · doi:10.15835/nsb11310443 · Cited by 1

La resistencia a antibióticos: El efecto colateral

Gil, L. P. (2014) · Horizonte Sanitario · doi:10.19136/hs.a11n1.108 · Cited by 1

UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS FARMACÊUTICAS ASPECTOS FENOTÍPICOS E PERFIL DE SUSCETIBILIDADE DE C. dubliniensis RESISTENTES AO FLUCONAZOL FRENTE A ANTIFÚNGICOS E ASSOCIAÇÕES

Scheid, L. A. (2007) · Cited by 1

Non-albicans Candida Infections

Sobel, J. D., & Revankar, S. G. (2014) · ASM Press eBooks · doi:10.1128/9781555815592.ch19

Fungemia por leveduras: perfis fenotípicos e moleculares e sensibilidade antifúngica de amostras isoladas no hospital das clínicas de Botucatu, São Paulo.

Ruiz, L. D. S. (2008) · doi:10.11606/t.42.2008.tde-25112008-103426

Proposed quality control ranges for 2-μg anidulafungin disk diffusion testing and ability of the method to detect strains with elevated echinocandin MIC values

Jones, R. N., Ross, J. E., & Sheehan, D. J. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.08.021

Bifonazole in vitro activity and its azole-parallel resistance in clinical yeast isolates

Czaika, V. A., Tietz, H. J., & Schmalreck, A. (2014) · JOURNAL OF ADVANCES IN BIOLOGY · doi:10.24297/jab.v6i1.5463

Caracterização e Identificação de Fungos Causadores de Infecções Nosocomiais em Pacientes Transplantados de Células Tronco Hematopoiéticas

Camplesi, M. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Echinocandins – Caspofungin, Anidulafungin and Micafungin

Lewis, R. E., & Kontoyiannis, D. P. (2010) · CRC Press eBooks · doi:10.1201/b13787-145

Emerging Resistance AmongCandidaSpecies: Trends and Treatment Considerations for Candidemia

Lee, I., & Zaoutis, T. E. (2007) · Infectious disease and therapy · doi:10.3109/9781420017236.012

"PEPTÍDEOS ANTIMICROBIANOS DO VENENO DE Avicularia juruensis (Mygalomorphae, Theraphosidae)"

Ayroza, G. (2012)

Antifungal tedavide son gelişmeler

Kaan, K. (2008) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.1501/eczfak_0000000491

The effect of a combination therapy of Fluconazole and Amphotericin B on the growth and CDR1 gene expression of Candida glabrata

Mohamed, N. A. N. (2020) · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape)

Estudio proteómico y efecto de la modulación de la vía Calmodulina/Calcineurina en aislamientos de Candida glabrata resistentes a caspofungina

Garzón, C. A. C. (2021) · theses.fr (ABES) · doi:10.70675/ca271ae5zda04z430ezad9fza9c5574a23ad

Micafungin exposure drives multidrug resistance in Clavispora lusitaniaePreprint

Wash, E., Scott, N. E., Metzner, K., Zhou, X., Dasilva, D., de Sá, N. P., Usmani, S. A., Sa, N. F. V. D., Poeta, M. D., & Selmecki, A. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.29.735437

Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis. 2006; 42(7): 938944

Krogh-madsen, M., Arendrup, M. C., Heslet, L., & Knudsen, J. D. (2016)

Cholesterol dependent and Amphotericin B resistant isolates of aCandida glabratastrain from an Intensive Care Unit patient

Rezusta, A., Aspíroz, C., Boekhout, T., Cano, J., Theelen, B., Guarro, J., & Rubio, M. C. (2008) · Medical Mycology · doi:10.1080/13693780701636898 · Cited by 7

Emergence of multiple resistance profiles involving azoles, echinocandins and amphotericin B in Candida glabrata isolates from a neutropenia patient with prolonged fungaemia

Cho, E., Shin, J. H., Kim, S. H., Kim, H., Park, J. S., Sung, H., Kim, M., & Im, H. J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku518 · Cited by 36

Genetic diversity, antifungal susceptibility and enzymatic characterisation of Malaysian clinical isolates of Candida glabrata.

Lotfalikhani, A., Khosravi, Y., Sabet, N. S., Na, S. L., Ng, K. P., & Tay, S. T. (2018) · PubMed · Cited by 2

Molecular Characterization and In Vitro Antifungal Susceptibility of Candida Glabrata Clinical Isolates with Reduced Echinocandin Susceptibility and High Level Multi-Azole Resistance

Baxa, J. A. V. D. (2014) · Clinical Microbiology Open Access · doi:10.4172/2327-5073.1000154 · Cited by 2